Immobilization strategies for single-chain antibody microarrays

Proteomics

Volumn 8, Issue 11, 2008, Pages 2199-2210

  Seurynck Servoss, Shannon L ^a   Baird, Cheryl L ^a   Miller, Keith D ^a   Pefaur, Noah B ^a   Gonzalez, Rachel M ^a   Apiyo, David O ^a   Engelmann, Heather E ^a   Srivastava, Sudhir ^b   Kagan, Jacob ^b   Rodland, Karin D ^a   Zangar, Richard C ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antibody microarray; ELISA; Single chain antibodies

Indexed keywords

ANTIBODY; EPIDERMAL GROWTH FACTOR; HYBRID PROTEIN; THIOREDOXIN;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN IMMOBILIZATION; PROTEIN MICROARRAY; PROTEIN SYNTHESIS;

ANIMALS; ANTIBODIES; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; EPITOPES; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN VARIABLE REGION; MICE; PROTEIN ARRAY ANALYSIS; PROTEINS; PROTEOMICS; THIOREDOXINS;

EID: 46049090245     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200701036     Document Type: Article

References (23)

1. Liang, S. L., Chan, D. W., Enzymes and related proteins as cancer biomarkers: A proteomic approach. Clin. Chim. Acta 2007, 381, 93-97.
2. Mor, G., Visintin, I., Lai, Y., Zhao, H. et al., Serum protein markers for early detection of ovarian cancer. Proc. Natl. Acad. Sci. USA 2005, 102, 7677-7682.
3. Terry, K. L., Sluss, P. M., Skates, S. J., Mok, S. C. et al., Blood and urine markers for ovarian cancer: A comprehensive review. Dis. Markers 2004, 20, 53-70.
4. Zhang, Z., Bast, R. C., Yu, Y. H., Li, J. N. et al., Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004, 64, 5882-5890.
5. Zangar, R. C., Daly, D. S., White, A. M., ELISA microarray technology as a high-throughput system for cancer biomarker validation. Expert Rev. Proteomics 2006, 3, 37-44.
6. Blazek, D., Celer, V., The production and application of single-chain antibody fragments. Folia Microbiol. 2003, 48, 687-698.
7. Holliger, P., Hudson, P. J., Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 2005, 23, 1126-1136.
8. Steinhauer, C., Wingren, C., Hager, A. C. M., Borrebaeck, C. A. K., Single framework recombinant antibody fragments designed for protein chip applications. BioTechniques 2002, 33, 38-45.
9. Steinhauer, C., Wingren, C., Khan, F., He, F. C. et al., Improved affinity coupling for antibody microarrays: Engineering of double-(His)6-tagged single framework recombinant antibody fragments. Proteomics 2006, 6, 4227-4234.
10. Wingren, C., Steinhauer, C., Ingvarsson, J., Persson, E. et al., Microarrays based on affinity-tagged single-chain Fv antibodies: Sensitive detection of analyte in complex proteomes. Proteomics 2005, 5, 1281-1291.
11. Jurado, P., de Lorenzo, V., Fernandez, L. A., Thioredoxin fusions increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: Evidence that chaperone activity is the prime effect of thioredoxin. J. Mol. Biol. 2006, 357, 49-61.
12. Jurado, P., Ritz, D., Beckwith, J., de Lorenzo, V., Fernandez, L. A., Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli. J. Mol. Biol. 2002, 320, 1-10.
13. Proba, K., Ge, L. M., Pluckthun, A., Functional antibody single-chain fragments from the cytoplasm Of Escherichia. coli - influence of thioredoxin reductase (Trxb). Gene 1995, 159, 203-207.
14. Colby, D. W., Kellogg, B. A., Graff, C. P., Yeung, Y. A. et al., Engineering antibody affinity by yeast surface display. Meth. Enzymol. 2004, 388, 348-358.
15. Boder, E. T., Wittrup, K. D., Yeast surface display for directed evolution of protein expression, affinity, and stability. Meth. Enzymol. 2000, 328, 430-444.
16. Feldhaus, M. J., Siegel, R. W., Opresko, L. K., Coleman, J. R. et al., Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat. Biotechnol. 2003, 21, 163-170.
17. Miller, K. D., Weaver-Feldhaus, J., Gray, S. A., Siegel, R. W., Feldhaus, M. J., Production, purification, and characterization of human scFv antibodies expressed in Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coli. Protein Expr. Purif. 2005, 42, 255-267.
18. Gonzalez, R. M., Seurynck-Servoss, S. L., Crawley, S. A., Brown, M. et al., Development and validation of sandwich ELISIA microarrays with minimal assay interference. J. Proteome Res. 2008, in press.
19. Daly, D. S., White, A. M., Varnum, S. M., Anderson, K. K., Zangar, R. C., Evaluating concentration estimation errors in ELISA microarray experiments. BMC Bioinformatics 2005, 6, 17.
20. White, A. M., Daly, D. S., Varnum, S. M., Anderson, K. K. et al., ProMAT: Protein microarray analysis tool. Bioinformatics 2006, 22, 1278-1279.
21. Seurynck-Servoss, S. L., White, A. M., Baird, C. L., Rodland, K. D., Zangar, R. C., Evaluation of surface chemistries for antibody microarrays. Anal. Biochem. 2007, 371, 105.
22. Chen, W. N. U., Woodbury, R. L., Kathmann, L. E., Opresko, L. K. et al., Induced autocrine signaling through the epidermal growth factor receptor contributes to the response of mammary epithelial cells to tumor necrosis factor alpha. J. Biol. Chem. 2004, 279, 18488-18496.
23. Bidart, J. M., Thuillier, F., Augereau, C., Chalas, J. et al., Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring. Clin. Chem. 1999, 45, 1695-1707.